The Global Age Related Macular Degeneration (AMD) Market report for by Type (dry age-related macular degeneration (DAMD) and wet age-related macular degeneration (WAMD)), by drug (Lucentis , Eylea, Avastin and Others), by stage (intermediate stage age related macular degeneration, early-stage age related macular degeneration and late stage age related macular degeneration), by age group(above 75 year, above 60 year and above 40 year), by Route of Administration(Intravenous and Intravitreal), by end user (hospitals & clinics, dignostic centers and academic research institutes)by geography (North America, Europe, Asia Pacific, Middle East & Africa and South America)) is expected to reach US $ XX Bn by 2026, at a CAGR of XX %.
The market for the global age-related macular degeneration (AMD) market has witnessed significant growth over the last decade because of the introduction of various promising drugs. The market is expected to experience a modest growth rate during the forecast period due to the absence of promising products in the pipeline or expected launches.
The Development of gene therapy for AMD is one of the latest trends witnessing in the global age-related macular degeneration (AMD) market.
In the current market scenario, only a few drugs are approved for the management of AMD. Conversely, the side effects related to them are severe, and the majority of them act in contradiction of VEGF only. The huge unmet need for safe and novel drugs to treat AMD are expected to drive the market growth. Anti-VEGF therapies need repetitive and inconvenient intraocular injections. An inconvenience and discomfort factor concerning frequent injections in the eye, patient compliance is a significant unease with anti-VEGF therapies. In the future, several key players are expected to work on novel drugs against AMD. So, the development of gene therapy is expected to become a trend for the global AMD therapeutics market.
The Asia Pacific region is projected to be a leading region in the global age-related macular degeneration (AMD) market.
The Asia Pacific region is estimated to accounts for one-third of the macular degeneration cases registered across the globe, which is projected to increase during the forecast period. The presence of the aged population is expected to drive the growth in the age-related macular degeneration (AMD) market. Additionally, the government of countries includes South Korea and Malaysia have introduced some health insurance plans to insure the cost of the treatment the increase in the government initiatives are boosting the age-related macular degeneration market growth in the Asia Pacific region.
Key players operating in the global age related macular degeneration (AMD) Market includes Kubota Pharmaceutical Holdings Co. Ltd., Alimera Sciences Inc., Adverum Biotechnologies Inc., Gilead Sciences Inc., Apellis Pharmeceuticals Inc., F. Hoffmann-La Roche Ltd., Allergan plc., Bausch Health Companies Inc, Regeneron Pharmaceuticals Inc., Neurotics Pharmaceuticals Inc., Ophthotech Corporation, Novartis AG, Pfizer Inc., GlaxoSmithKline plc. and Bayer AG.
Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the global age related macular degeneration (AMD) Market. The report encompasses the market by different segments and region, providing an in-depth analysis of the overall industry ecosystem, useful for making an informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the market, further giving an insight into the market dynamics, and future opportunities that might exist in the global age related macular degeneration (AMD) market. The driving forces, as well as considerable restraints, have been explained in depth. In addition to this, competitive landscape describing the strategic growth of the competitors have been taken into consideration for enhancing market know-how of our clients and at the same time explain global age related macular degeneration (AMD) market positioning of competitors.
Browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global Age Related Macular Degeneration (AMD) Market”
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, VadgaonBk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607065656